MCD vs STOK · P/E 23, rev $25.92B vs rev $36.6M
McDonald’s Corporation (MCD) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. STOK currently screens at market cap $1.88B.
Not investment advice. Open the MCD and STOK stock pages for the full models.
Not investment advice.